<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (date of earliest event
reported): <B>February 15, 2012</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Synthetic Biologics, Inc.</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified
in charter)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Nevada</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction of incorporation)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; padding: 0; line-height: 115%; font-weight: bold; text-align: center"><B>01-12584 &nbsp;</B></TD>
    <TD STYLE="width: 4%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 47%; padding: 0; line-height: 115%; font-weight: bold; text-align: center"><B>13-3808303 &nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; line-height: 115%; text-align: center">&nbsp;(Commission File Number)</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: center">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: center">&nbsp;(IRS Employer Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>3985 Research Park Drive, Suite 200</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Ann Arbor, MI 48108</B></P>

<P STYLE="font: 10pt/0.75pt Times New Roman, Times, Serif; margin: 8.5pt 0 0; text-align: center; background-color: black">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 8.5pt 0 0; text-align: center">(Address of principal executive
offices and zip code)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(734) 332-7800</B></P>

<P STYLE="font: 10pt/0.75pt Times New Roman, Times, Serif; margin: 8.5pt 0 0; text-align: center; background-color: black">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 8.5pt 0 0; text-align: center">(Registrant&rsquo;s telephone
number including area code)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Adeona Pharmaceuticals, Inc.</P>

<P STYLE="font: 10pt/0.75pt Times New Roman, Times, Serif; margin: 8.5pt 0 0; text-align: center; background-color: black">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 8.5pt 0 0; text-align: center">(Former Name and Former Address)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 6%; padding: 0; line-height: 115%"><FONT STYLE="font-family: Wingdings">o</FONT></TD>
    <TD STYLE="width: 88%; padding: 0; line-height: 115%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 6%; padding: 0; line-height: 115%"><FONT STYLE="font-family: Wingdings">o</FONT></TD>
    <TD STYLE="width: 88%; padding: 0; line-height: 115%">Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; width: 6%"><FONT STYLE="font-family: Wingdings">o</FONT></TD>
    <TD STYLE="width: 88%; padding: 0; line-height: 115%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 6%; padding: 0; line-height: 115%"><FONT STYLE="font-family: Wingdings">o</FONT></TD>
    <TD STYLE="width: 88%; padding: 0; line-height: 115%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 5.03</B>&nbsp;&nbsp;&nbsp;<B>Amendments to Articles
of Incorporation or Bylaws; Change in Fiscal Year</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 15, 2012, the Company filed
an amendment to its articles of incorporation to effectuate a change in the Company&rsquo;s name from Adeona Pharmaceuticals, Inc.
to Synthetic Biologics, Inc. effective immediately. A copy of the Certificate of Amendment to the Articles of Incorporation is
furnished as Exhibit 3.1 hereto.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 5.07 &nbsp;&nbsp;</B> <B>Submission of Matters to
a Vote of Security Holders.</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 15, 2012, Synthetic Biologics,
Inc. (formerly, Adeona Pharmaceuticals, Inc., the &ldquo;Company&rdquo;)&nbsp;held a Special Meeting of Stockholders (the &ldquo;Meeting&rdquo;).&nbsp;The
matter voted on at the Meeting was an amendment to the Company&rsquo;s articles of incorporation to effectuate a change in the
Company&rsquo;s name from Adeona Pharmaceuticals, Inc. to Synthetic Biologics, Inc. The proposal, which was approved by the required
number of votes, was passed by a majority of the outstanding shares of common stock.&nbsp;In addition, the Company issued a press
release regarding the results of the Meeting that is furnished as Exhibit 99.1 hereto. The final voting results were as follows:</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; padding: 0; line-height: 115%; font-weight: bold">Name Change</TD>
    <TD STYLE="padding: 0; line-height: 115%; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; padding: 0; line-height: 115%; font-weight: bold; text-align: center">For</TD>
    <TD STYLE="padding: 0; line-height: 115%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; padding: 0; line-height: 115%; font-weight: bold; text-align: center">Against</TD>
    <TD STYLE="padding: 0; line-height: 115%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; padding: 0; line-height: 115%; font-weight: bold; text-align: center">Abstained</TD>
    <TD STYLE="padding: 0; line-height: 115%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; padding: 0">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><B>Broker</B></P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><B>Non-votes</B></P></TD>
    <TD STYLE="padding: 0; line-height: 115%; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 55%; padding: 0; line-height: 115%; text-indent: -0.25in">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 9%; padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 8%; padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 8%; padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 8%; padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">21,264,514&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">95,437&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">291,718&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">0&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: right">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 9.01.&nbsp;&nbsp;&nbsp;Financial
Statements and Exhibits</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following exhibits
are being filed as part of this Report.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; border-bottom: black 1.5pt solid; padding: 0">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>Exhibit</B></P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>Number</B></P></TD>
    <TD STYLE="width: 83%; border-bottom: black 1.5pt solid; padding: 0">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0">&nbsp;</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>Description</B></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="line-height: 115%; text-align: center; padding: 0">3.1</TD>
    <TD STYLE="line-height: 115%; padding: 0">Certificate of Amendment to the Articles of Incorporation of the Company</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="line-height: 115%; text-align: center; padding: 0">&nbsp;99.1</TD>
    <TD STYLE="padding: 0">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Press Release dated February 16, 2012 regarding the
        results of the Special Meeting of Stockholders held on February 15, 2012.</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: justify"></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="padding: 0; line-height: 115%">Dated February 16, 2012</TD>
    <TD COLSPAN="2" STYLE="padding: 0; line-height: 115%">Adeona Pharmaceuticals, Inc.</TD></TR>
<TR>
    <TD STYLE="padding: 0; line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; line-height: 115%">(Registrant)</TD></TR>
<TR>
    <TD STYLE="padding: 0; line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; line-height: 115%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 50%; padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 5%; padding: 0; line-height: 115%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1.5pt solid; padding: 0; line-height: 115%">/s/ Jeff Riley</TD></TR>
<TR>
    <TD STYLE="padding: 0; line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; line-height: 115%">Name: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jeff Riley</TD></TR>
<TR>
    <TD STYLE="padding: 0; line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; line-height: 115%">Title: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chairman</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; border-bottom: black 1.5pt solid; padding: 0">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>Exhibit</B></P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>Number</B></P></TD>
    <TD STYLE="width: 83%; border-bottom: black 1.5pt solid; padding: 0">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0">&nbsp;</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>Description</B></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="line-height: 115%; text-align: center; padding: 0">3.1</TD>
    <TD STYLE="line-height: 115%; padding: 0">Certificate of Amendment to the Articles of Incorporation of the Company</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="line-height: 115%; text-align: center; padding: 0">&nbsp;99.1</TD>
    <TD STYLE="padding: 0">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Press Release dated February 16, 2012 regarding
the results of the Special Meeting of Stockholders held on February 15, 2012.&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="line-height: 115%; padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; line-height: 115%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 8.5pt 0 0; text-align: right"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 8.5pt 0 0; text-align: right">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v302955_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 23514}]
{"company-data": {"conformed-name": "ADEONA PHARMACEUTICALS, INC.", "cik": "0000894158", "assigned-sic": "2834", "irs-number": "133808303", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-12584", "film-number": "12617806"}, "business-address": {"street1": "3930 VARSITY DRIVE", "city": "ANN ARBOR", "state": "MI", "zip": "48108", "phone": "734-332-7800"}, "mail-address": {"street1": "3930 VARSITY DRIVE", "city": "ANN ARBOR", "state": "MI", "zip": "48108"}, "former-company": [{"former-conformed-name": "PIPEX PHARMACEUTICALS, INC.", "date-changed": "20061214"}, {"former-conformed-name": "SHEFFIELD PHARMACEUTICALS INC", "date-changed": "19970730"}, {"former-conformed-name": "SHEFFIELD MEDICAL TECHNOLOGIES INC", "date-changed": "19940606"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (date of earliest event
reported):
February 15, 2012
Synthetic Biologics, Inc.
(Exact name of registrant as specified
in charter)
Nevada
(State or other jurisdiction of incorporation)
01-12584
13-3808303
(Commission File Number)
(IRS Employer Identification No.)
3985 Research Park Drive, Suite 200
Ann Arbor, MI 48108
(Address of principal executive
offices and zip code)
(734) 332-7800
(Registrant's telephone
number including area code)
Adeona Pharmaceuticals, Inc.
(Former Name and Former Address)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.03
Amendments to Articles
of Incorporation or Bylaws; Change in Fiscal Year
On February 15, 2012, the Company filed
an amendment to its articles of incorporation to effectuate a change in the Company's name from Adeona Pharmaceuticals, Inc.
to Synthetic Biologics, Inc. effective immediately. A copy of the Certificate of Amendment to the Articles of Incorporation is
furnished as Exhibit 3.1 hereto.
Item 5.07
Submission of Matters to
a Vote of Security Holders.
On February 15, 2012, Synthetic Biologics,
Inc. (formerly, Adeona Pharmaceuticals, Inc., the "Company") held a Special Meeting of Stockholders (the "Meeting"). The
matter voted on at the Meeting was an amendment to the Company's articles of incorporation to effectuate a change in the
Company's name from Adeona Pharmaceuticals, Inc. to Synthetic Biologics, Inc. The proposal, which was approved by the required
number of votes, was passed by a majority of the outstanding shares of common stock. In addition, the Company issued a press
release regarding the results of the Meeting that is furnished as Exhibit 99.1 hereto. The final voting results were as follows:
Name Change
For
Against
Abstained
Broker
Non-votes
21,264,514
95,437
291,718
0
Item 9.01.   Financial
Statements and Exhibits
(d)           Exhibits
The following exhibits
are being filed as part of this Report.
Exhibit
Number
Description
3.1
Certificate of Amendment to the Articles of Incorporation of the Company
99.1
Press Release dated February 16, 2012 regarding the
        results of the Special Meeting of Stockholders held on February 15, 2012.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated February 16, 2012
Adeona Pharmaceuticals, Inc.
(Registrant)
By:
/s/ Jeff Riley
Name:      Jeff Riley
Title:       Chairman
EXHIBIT INDEX
Exhibit
Number
Description
3.1
Certificate of Amendment to the Articles of Incorporation of the Company
99.1
Press Release dated February 16, 2012 regarding
the results of the Special Meeting of Stockholders held on February 15, 2012.